Despite a lack of disease-modifying treatments for Alzheimer’s disease, progress is being made in research, particularly genetic and immunologic data. Speaking from the Alzheimer’s Research UK Conference 2018, held in London, UK, Tara Spires-Jones, BA, BSc, MSc, PhD, of the University of Edinburgh, Edinburgh, UK, discusses the exciting progress being made in Alzheimer’s research both nationally and internationally, highlighting an attractive therapeutic target.